BDSX (BDSX) Stock Price & Analysis
BDSX (BDSX) fell 1.11% to USD 26.18 as of September 8, 2026 at 13:16 UTC, according to Nexqual real-time market data.
BDSX last closed at USD 26.18; the session ranged USD 25.42–26.76 on volume of 58,780 shares. Market capitalization is —, with a 52-week range of USD 5.26–31.31 (NGM). Source: Nexqual, September 8, 2026 at 13:16 UTC.
Key Statistics (as of September 8, 2026 at 13:16 UTC)
| Price | USD 26.18 |
|---|---|
| Change | ▼ 1.11% (down) |
| Previous Close | USD 26.18 |
| Open | USD 26.18 |
| Day Range | USD 25.42 – 26.76 |
| 52-Week Range | USD 5.26 – 31.31 |
| Volume | 58,780 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (BDSX)
Nexqual's technical model rates BDSX "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 13:16 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 53.84 (neutral) |
| vs SMA50 | Above (USD 23.31) |
| MACD | 1.19 (positive) |
From BDSX's Latest SEC 10-K Filing (filed 2026-02-26)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AFIB | Acutus Medical Inc. | USD 0 | ▲ 0% |
| ALGS | Aligos Therapeutics, Inc. | USD 6.21 | ▲ 0% |
| DMRA | Damora Therapeutics, Inc. | USD 30.06 | ▲ 6.67% |
| NMAD | Nomad Power Solutions, Inc. | USD 4.03 | ▲ 8.63% |
| STTK | Shattuck Labs, Inc. | USD 6.79 | ▼ 1.74% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 13:16 UTC. This page is informational and not investment advice.